Da Volterra part of the 10 finalists for the Lyfebulb Helsinn Innovation Summit & Award in Oncology!

Da Volterra part of the 10 finalists for the Lyfebulb Helsinn Innovation Summit & Award in Oncology!


Back to news page

Da Volterra part of the 10 finalists for the Lyfebulb Helsinn Innovation Summit & Award in Oncology!

We are thrilled to announce we are part of the ten finalists for the Lyfebulb Helsinn 2019 Innovation Summit in Oncology taking place in Monaco on March 18-19. This is the recognition of the excellence of our programs and their potential benefits for patients suffering of cancer.

Lyfebulb is a patient empowerment platform that connects patients, industry and investors to support user-driven innovation toward solutions in chronic disease, and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care.

Lyfebulb Helsinn Press Release is available here

More information on the event is available here